Literature DB >> 26975387

Urinary tract infection in infants caused by extended-spectrum beta-lactamase-producing Escherichia coli: comparison between urban and rural hospitals.

Ming-Fang Cheng1,2,3, Wan-Ling Chen1,2,4, I-Fei Huang1,2, Jung-Ren Chen5, Yee-Hsuan Chiou1,2,3, Yao-Shen Chen2,6, Susan Shin-Jung Lee2,6, Wan-Yu Hung7, Chih-Hsin Hung8, Jiun-Ling Wang9.   

Abstract

BACKGROUND: Community-acquired urinary tract infection (UTI) caused by extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli is an emerging problem. Compared with urban infants, rural infants may encounter different distributions of community-acquired resistant strains and various barriers to efficient management.
METHODS: A retrospective survey and comparison was conducted for infants with UTI caused by ESBL-producing E. coli admitted to an urban hospital (n = 111) and a rural hospital (n = 48) in southern Taiwan from 2009 to 2012.
RESULTS: Compared with 2009 and 2010, the total number of cases at both hospitals significantly increased in 2011 and 2012 (p < 0.001). Compared with the rural patients, the urban patients were significantly younger, and they had fewer days of fever before and after admission, fewer presentations of poor activity and poor appetite, and a lower serum creatinine level. Most of the patients had no prior history of illness, and we could not identify any significant different risk factors for acquiring ESBL-producing E. coli, such as past antimicrobial use, hospitalization, UTI, and underlying renal diseases, between the urban and rural populations.
CONCLUSIONS: The increase in community-acquired UTI in infants caused by ESBL-producing E. coli was similar between the urban and rural populations. Our preliminary data suggest that the rural-urban disparities were probably related to easy access to health care by the urban population. ESBL complicates disease management, and the increase in the prevalence of ESBL producers is a major health concern and requires further healthy carrier and environmental surveillance.

Entities:  

Keywords:  Antimicrobial resistance; Child; Epidemiology; Health disparity; Rural health

Mesh:

Year:  2016        PMID: 26975387     DOI: 10.1007/s00467-016-3338-0

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  32 in total

1.  Emergence of extended spectrum-β-lactamase-producing Escherichia coli O25b-ST131: a major community-acquired uropathogen in infants.

Authors:  Ming-Fang Cheng; Wan-Ling Chen; Wan-Yu Hung; I-Fei Huang; Yee-Hsuan Chiou; Yao-Shen Chen; Susan Shin-Jung Lee; Chih-Hsin Hung; Jiun-Ling Wang
Journal:  Pediatr Infect Dis J       Date:  2015-05       Impact factor: 2.129

Review 2.  Diagnosis and management of urinary tract infection in children: summary of NICE guidance.

Authors:  Rintaro Mori; Monica Lakhanpaul; Kate Verrier-Jones
Journal:  BMJ       Date:  2007-08-25

3.  Prevalence of day-care centre children (France) with faecal CTX-M-producing Escherichia coli comprising O25b:H4 and O16:H5 ST131 strains.

Authors:  Véronique Blanc; Véronique Leflon-Guibout; Jorge Blanco; Marisa Haenni; Jean-Yves Madec; Gwenaële Rafignon; Pascale Bruno; Azucena Mora; Cecilia Lopez; Ghizlane Dahbi; Brigitte Dunais; Magali Anastay; Catherine Branger; Richard Moreau; Christian Pradier; Marie-Hélène Nicolas-Chanoine
Journal:  J Antimicrob Chemother       Date:  2014-01-08       Impact factor: 5.790

Review 4.  Extended-spectrum beta-lactamases.

Authors:  A Philippon; R Labia; G Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

5.  Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Authors:  Javier Ena; Francisco Arjona; Carmen Martínez-Peinado; Maria Del Mar López-Perezagua; Concepción Amador
Journal:  Urology       Date:  2006-12       Impact factor: 2.649

6.  Extended-spectrum beta-lactamase (ESBL)-producing enterobacteria: factors associated with infection in the community setting, Auckland, New Zealand.

Authors:  C T Moor; S A Roberts; G Simmons; S Briggs; A J Morris; J Smith; H Heffernan
Journal:  J Hosp Infect       Date:  2008-03-19       Impact factor: 3.926

7.  Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004.

Authors:  James R Johnson; Megan Menard; Brian Johnston; Michael A Kuskowski; Kim Nichol; George G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

8.  Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases.

Authors:  Esther Calbo; Verónica Romaní; Mariona Xercavins; Lucía Gómez; Carolina Garcia Vidal; Salvador Quintana; Jordi Vila; Javier Garau
Journal:  J Antimicrob Chemother       Date:  2006-02-21       Impact factor: 5.790

9.  Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: a comparative study.

Authors:  Noam Dayan; Husein Dabbah; Irith Weissman; Ibrahim Aga; Lea Even; Daniel Glikman
Journal:  J Pediatr       Date:  2013-08-03       Impact factor: 4.406

10.  Community transmission of extended-spectrum beta-lactamase.

Authors:  Beatriz Mirelis; Ferran Navarro; Elisenda Miró; Raul Jesús Mesa; Pere Coll; Guillem Prats
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883

View more
  1 in total

1.  Antibiotic Resistance Pattern of Extended Spectrum Beta Lactamase Producing Escherichia coli Isolated From Patients With Urinary Tract Infection in Morocco.

Authors:  Mohamed Kettani Halabi; Fatima Azzahra Lahlou; Idrissa Diawara; Younes El Adouzi; Rabiaa Marnaoui; Rachid Benmessaoud; Imane Smyej
Journal:  Front Cell Infect Microbiol       Date:  2021-08-18       Impact factor: 5.293

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.